First Header Logo Second Header Logo

Connection

Katherine Poehling to Tennessee

This is a "connection" page, showing publications Katherine Poehling has written about Tennessee.
Connection Strength

0.552
  1. Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB. The burden of influenza in young children, 2004-2009. Pediatrics. 2013 Feb; 131(2):207-16.
    View in: PubMed
    Score: 0.108
  2. Poehling KA, Light LS, Rhodes M, Snively BM, Halasa NB, Mitchel E, Schaffner W, Craig AS, Griffin MR. Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology. 2010 May; 21(3):340-6.
    View in: PubMed
    Score: 0.090
  3. Poehling KA, Talbot HK, Williams JV, Zhu Y, Lott J, Patterson L, Edwards KM, Griffin MR. Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties. Vaccine. 2009 May 05; 27(20):2695-700.
    View in: PubMed
    Score: 0.083
  4. Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007 Apr; 119(4):707-15.
    View in: PubMed
    Score: 0.073
  5. Poehling KA, Lafleur BJ, Szilagyi PG, Edwards KM, Mitchel E, Barth R, Schwartz B, Griffin MR. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004 Sep; 114(3):755-61.
    View in: PubMed
    Score: 0.061
  6. Poehling KA, Szilagyi PG, Edwards K, Mitchel E, Barth R, Hughes H, Lafleur B, Schaffer SJ, Schwartz B, Griffin MR. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation. Pediatr Infect Dis J. 2003 May; 22(5):413-8.
    View in: PubMed
    Score: 0.055
  7. Talbot HK, Poehling KA, Williams JV, Zhu Y, Chen Q, McNabb P, Edwards KM, Griffin MR. Influenza in older adults: impact of vaccination of school children. Vaccine. 2009 Mar 18; 27(13):1923-7.
    View in: PubMed
    Score: 0.021
  8. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, Schaffner W, Craig AS, Griffin MR. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005 May 19; 352(20):2082-90.
    View in: PubMed
    Score: 0.016
  9. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004 Sep 01; 39(5):641-8.
    View in: PubMed
    Score: 0.015
  10. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004 Aug; 23(8):726-31.
    View in: PubMed
    Score: 0.015
  11. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004 Jun; 113(6):1758-64.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.